|
|
???tair.name??? >
???browser.page.title.author???
|
"gubens m a"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2021 |
Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLC
|
Herbst, R.S.;Garon, E.B.;Kim, D.-W.;Cho, B.C.;Gervais, R.;Perez-Gracia, J.L.;Han, J.-Y.;Majem, Majem M.;Forster, M.D.;Monnet, I.;Novello, S.;Gubens, M.A.;Boyer, M.;Su, W.-C.;Samkari, A.;Jensen, E.H.;Kobie, J.;Piperdi, B.;Baas, P. |
| 國立成功大學 |
2020 |
Long-term outcomes and retreatment among patients with previously treated, programmed death-ligand 1‒positive, advanced non‒small-cell lung cancer in the KEYNOTE-010 study
|
Herbst, R.S.;Garon, E.B.;Dong-Wan, K.;Cho, B.C.;Perez-Gracia, J.L.;Ji-Youn, H.;Arvis, C.D.;Majem, Majem M.;Forster, M.D.;Monnet, I.;Novello, S.;Szalai, Z.;Gubens, M.A.;Wu-Chou, S.;Ceresoli, G.L.;Samkari, A.;Jensen, E.H.;Lubiniecki, G.M.;Baas, P. |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
